News
Discover if this celebrity-backed supplement truly helps with hunger control, fat reduction, and weight management.
Pharma giant Eli Lilly’s weight loss drug Mounjaro is priced between Rs. 10,000- ₹15,000 in India making it inaccessible to a ...
South Carolina Medicaid approved GLP-1s to treat obesity, placing it among the few state programs covering the drugs. But ...
Indian drug cos are increasing their presence in the insulin market. They are competing with multinational corporations.
For patients with overweight/obesity and/or diabetes, glucagon-like peptide 1 receptor agonist (GLP-1 RA) treatment is not ...
Despite the popularity of semaglutide drugs like Ozempic and Wegovy for weight loss, surveys suggest that most people still ...
You’ve likely heard the hype around Ozempic and Wegovy – weight loss drugs that have taken the world by storm. These ...
Cognitive performance was not different among four classes of glucose-lowering medications for type 2 diabetes, data from the ...
17h
Health on MSNThis New Pill Could Rival Ozempic and Wegovy—Will It Make Weight Loss Drugs More Accessible?Eli Lilly plans to pursue approval for its new GLP-1 pill by the end of this year. Fact checked by Nick Blackmer A daily pill ...
A popular pharmaceutical intervention for weight loss may also have the potential to curb alcoholism, as researchers observed a “commonality of function.” Between those who swear by […] ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results